NFKB1 and diffuse large B-cell lymphoma of the central nervous system: Activation of the NF-κB pathway, either directly or indirectly via activation of the B-cell receptor pathway, could represent an alternative mechanism of MYC deregulation in CNS DLBCL, since NF-κB is a known transcriptional activator of MYC[3].